← All trials
NCT03348592
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2016
- Primary completion
- Nov 30, 2017
- Completion date
- Jun 30, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 18
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Lead sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Study director
- University of PennsylvaniaCollaborator
- George Washington UniversityCollaborator
- The Cleveland ClinicReponsible party - principal investigator
- The Cleveland ClinicOverall official - principal investigator
- Department of Veteran AffairsStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.